Xcout Intel
Celea Therapeutics
Celea Therapeutics is a biopharmaceutical company focused on advancing transformative treatments for serious respiratory diseases.
Subscribe to see Celea Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Celea Therapeutics at a glance
Celea Therapeutics is a biotech company. Xcout tracks 4 named people at Celea Therapeutics, including Sven Dethlefs (Chief Executive Officer). Xcout recorded 18 job postings from Celea Therapeutics in the last 90 days.
Celea Therapeutics leadership
- Sven DethlefsChief Executive Officer
- Camilla GrahamMedical Affairs
- David GolodClinical Operations & Program Strategy
- Neera JainChemistry, Manufacturing, and Controls
Hiring at Celea Therapeutics
Xcout recorded 18 job postings from Celea Therapeutics in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Celea Therapeutics's hiring signals →
Tech stack
Celea Therapeutics competitors
A few of Celea Therapeutics's closest competitors — see the full list of competitors and alternatives →
Sunterra Bio is a biopharmaceutical company focused on developing inhaled small-molecule therapies for rare pulmonary diseases. Headquartered in Carlsbad, California, the company advances targeted treatments for respiratory conditions.
Altesa BioSciences is a clinical-stage pharmaceutical company headquartered in College Park, Georgia. The company is dedicated to improving the lives of individuals suffering from chronic lung diseases, including conditions such as COPD and asthma.
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
Aer Therapeutics, Inc. is a biotechnology research company based in North Carolina focused on targeting mucus to improve lung health.
Sionna Therapeutics is a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, focused on developing treatments for cystic fibrosis.
RaeSedo Holding, Inc. is a biotechnology company developing a novel class of therapeutics for asthma. The company is creating surfactant protein-A (SP-A) derived peptide therapies designed to reduce inflammation, mucus, and airway constriction for asthma patients.
Get Celea Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Celea Therapeutics in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access